Summary
OraSure Technologies Inc (OraSure) is a manufacturer and distributor of oral fluid specimen collection devices, diagnostic products and other medical devices. Its product portfolio encompasses infectious disease tests for the detection of antibodies for the HIV and Hepatitis C virus; and antigens for influenza type A and type B. OraSure also sells immunoassay tests and reagents for insurance risk assessment, substance-abuse testing and forensic toxicology applications; and products for the cryosurgical removal of warts and several other benign skin lesions. The company distributes its products to various hospitals, clinics, community-based organizations and other public health organizations, distributors, clinical laboratories, and commercial and industrial entities. The company sells its products through distributors in the Americas, Europe and Asia-Pacific. OraSure is headquartered in Bethlehem, Pennsylvania, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company OraSure Technologies Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
OraSure Technologies Inc Company Overview 4
OraSure Technologies Inc Company Snapshot 4
OraSure Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview 4
OraSure Technologies Inc – Pipeline Analysis Overview 7
Business Description 7
OraSure Technologies Inc - Key Facts 8
OraSure Technologies Inc - Major Products and Services 9
OraSure Technologies Inc Pipeline Products by Development Stage 11
OraSure Technologies Inc Ongoing Clinical Trials by Trial Status 13
OraSure Technologies Inc Pipeline Products Overview 15
Next Generation OraQuick Rapid HIV Test 15
Next Generation OraQuick Rapid HIV Test Product Overview 15
OMNIgene•GUT OM-200 16
OMNIgene•GUT OM-200 Product Overview 16
OraQuick In-Home HIV Test 17
OraQuick In-Home HIV Test Product Overview 17
OraQuick In-Home HIV Test Clinical Trial 18
OraQuick Rapid Zika Virus Test 20
OraQuick Rapid Zika Virus Test Product Overview 20
OraSure Technologies Inc - Key Competitors 21
OraSure Technologies Inc - Key Employees 22
OraSure Technologies Inc - Key Employee Biographies 23
OraSure Technologies Inc - Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
OraSure Technologies Inc, Recent Developments 25
Mar 01, 2017: OraSure Receives Global Fund Classification to Enable HIV Self-Test Procurement 25
Feb 24, 2017: OraSure Technologies Announces Director Retirement 25
Feb 08, 2017: OraSure Announces 2016 Fourth Quarter and Full-Year Financial Results 25
Feb 06, 2017: OraSure Technologies Announces Settlement of Litigation with Ancestry.comDNA 26
Nov 29, 2016: OraSure to Implement $18 Million Product Supply Contract From Foreign Government for HCV Elimination Program 27
Nov 29, 2016: Helix Selects DNA Genotek’s Oragene Collection Device and GenoFIND Fulfillment Services for Genetic Discovery Applications 27
Nov 15, 2016: OraSure Technologies Appoints Stephen S. Tang, Ph.D. as Chairman of the Board of Directors 28
Nov 02, 2016: OraSure Announces 2016 Third Quarter Financial Results 28
Aug 29, 2016: DNA Genotek’s OMNIgene GUT Kit is Proposed as Standardized Test for Worldwide Studies of the Human Microbiome 29
Aug 23, 2016: HHS awards $7 Million to OraSure to Speed Development of Zika Diagnostic Test 30
Appendix 32
Methodology 32
About GlobalData 34
Contact Us 34
Disclaimer 34
List of Tables
OraSure Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview 4
OraSure Technologies Inc Pipeline Products by Equipment Type 5
OraSure Technologies Inc Pipeline Products by Indication 6
OraSure Technologies Inc Ongoing Clinical Trials by Trial Status 6
OraSure Technologies Inc, Key Facts 8
OraSure Technologies Inc, Major Products and Services 9
OraSure Technologies Inc Number of Pipeline Products by Development Stage 11
OraSure Technologies Inc Pipeline Products Summary by Development Stage 12
OraSure Technologies Inc Ongoing Clinical Trials by Trial Status 13
OraSure Technologies Inc Ongoing Clinical Trials Summary 14
Next Generation OraQuick Rapid HIV Test - Product Status 15
Next Generation OraQuick Rapid HIV Test - Product Description 15
OMNIgene•GUT OM-200 - Product Status 16
OMNIgene•GUT OM-200 - Product Description 16
OraQuick In-Home HIV Test - Product Status 17
OraQuick In-Home HIV Test - Product Description 17
OraQuick In-Home HIV Test - Community-based Distribution of Oral HIV Self-testing Kits-a Pilot Intervention and Rapid Impact Evaluation 18
OraQuick In-Home HIV Test - Increasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality Intervention: South Florida Center for Reducing Health Disparities 18
OraQuick In-Home HIV Test - Self-testing for HIV (HIVST) Amongst Urban, Peri-urban and Rural Communities in Zambia, Including a Cluster-randomised Trial of Community-based HIVST Distribution 19
OraQuick Rapid Zika Virus Test - Product Status 20
OraQuick Rapid Zika Virus Test - Product Description 20
OraSure Technologies Inc, Key Employees 22
OraSure Technologies Inc, Key Employee Biographies 23
OraSure Technologies Inc, Other Locations 24
OraSure Technologies Inc, Subsidiaries 24
Glossary 33
List of Figures
OraSure Technologies Inc Pipeline Products by Equipment Type 5
OraSure Technologies Inc Pipeline Products by Development Stage 11
OraSure Technologies Inc Ongoing Clinical Trials by Trial Status 13
